Is There a Role for Sequential in Sequential Anti-H. pylori Therapy?

Gastroenterology

Volumn 130, Issue 6, 2006, Pages 1930-

  Graham, David Y ^a   Lu, Hong ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLARITHROMYCIN; AMOXICILLIN PLUS METRONIDAZOLE; ANTIBIOTIC AGENT; CLARITHROMYCIN; CLARITHROMYCIN PLUS METRONIDAZOLE; METRONIDAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LETTER; PRIORITY JOURNAL;

EID: 33646347608     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.03.037     Document Type: Letter

References (12)

1. Francavilla R., Lionetti E., Castellaneta S.P., Magista A.M., Boscarelli G., Piscitelli D., Amoruso A., Di L.A., Miniello V.L., Francavilla A., Cavallo L., and Ierardi E. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children. a randomized trial. Gastroenterology 129 (2005) 1414-1419
2. De Francesco V., Della V.N., Stoppino V., Amoruso A., Muscatiello N., Panella C., and Ierardi E. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 19 (2004) 993-998
3. Zullo A., Vaira D., Vakil N., Hassan C., Gatta L., Ricci C., De Francesco V., Menegatti M., Tampieri A., Perna F., Rinaldi V., Perri F., Papadia C., Fornari F., Pilati S., Mete L.S., Merla A., Poti R., Marinone G., Savioli A., Campo S.M., Faleo D., Ierardi E., Miglioli M., and Morini S. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 17 (2003) 719-726
4. Zullo A., Gatta L., De Francesco V., Hassan C., Ricci C., Bernabucci V., Cavina M., Ierardi E., Morini S., and Vaira D. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer. a prospective controlled study. Aliment Pharmacol Ther 21 (2005) 1419-1424
5. Scaccianoce G., Hassan C., Panarese A., Piglionica D., Morini S., and Zullo A. Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen. Can J Gastroenterol 20 (2006) 113-117
6. Graham D.Y. Antibiotic resistance in Helicobacter pylori. implications for therapy. Gastroenterology 115 (1998) 1272-1277
7. Nakayama Y., and Graham D.Y. Helicobacter pylori infection. diagnosis and treatment. Expert Rev Anti-Infect Therapy 2 (2004) 599-616
8. Nagahara A., Miwa H., Ogawa K., Kurosawa A., Ohkura R., Iida N., and Sato N. Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy. Helicobacter 5 (2000) 88-93
9. Treiber G., Ammon S., Schneider E., and Klotz U. Amoxicillin/metronidazole/omeprazole/clarithromycin. a new, short quadruple therapy for Helicobacter pylori eradication. Helicobacter 3 (1998) 54-58
10. Treiber G., Wittig J., Ammon S., Walker S., van Doorn L.J., and Klotz U. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication. a randomized controlled trial (MACLOR study). Arch Intern Med 162 (2002) 153-160
11. Gisbert J.P., Marcos S., Gisbert J.L., and Pajares J.M. High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori eradication. Helicobacter 6 (2001) 157-162
12. Hopkins R.J. In search of the Holy Grail of Helicobacter pylori remedies. Helicobacter 6 (2001) 81-83